NCT03696290 - Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 19, 2019

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Bronchiectasis Adult

Interventions

DRUG

Aztreonam lysine

Nebulised aztreonam lysine 75mg

OTHER

Placebo

Nebulised lactose monohydrate 5mg

Trial Locations (14)

TQ2 7AA

RECRUITING

Torbay Hospital, Torquay

CB2 0AY

RECRUITING

Royal Papworth hospital NHS Foundation Trust, Cambridge

CF14 4HH

RECRUITING

Cardiff & Vale University Local Health Board, Cardiff

Unknown

RECRUITING

University Hospitals of Derby and Burton NHS Foundation Trust, Derby

RECRUITING

The Princess Alexandra Hospital NHS Trust, Harlow

RECRUITING

Aintree University Hospital, Liverpool

RECRUITING

Royal Brompton & Harefield NHS Foundation Trust, London

DD1 9SY

RECRUITING

NHS Tayside, Dundee

G75 8RG

RECRUITING

NHS Lanakrshire University Hospital Hairmyres, East Kilbride

L14 3PE

RECRUITING

Liverpool Heart and Chest Hospital, Liverpool

M13 9WL

RECRUITING

Manchester University NHS Foundation Trust - Wythenshawe Hospital, Manchester

NE7 7DN

RECRUITING

Freeman Hospital, Newcastle upon Tyne

SO16 6YD

RECRUITING

University hospital Southampton NHS Foundation Trust, Southampton

ML2 0DP

RECRUITING

NHS Lanarkshire: University Hospital Wishaw, Wishaw